Developmental Trajectory of the Endocannabinoid System in Human Dorsolateral Prefrontal Cortex

Overview

Journal BMC Neurosci

Publisher Biomed Central

Specialty Neurology

Date 2012 Jul 26

PMID 22827915

Citations 48

Authors

Leonora E Long

Jonna Lind

Maree Webster

Cynthia Shannon Weickert

Affiliations

Soon will be listed here.

Abstract

Background: Endocannabinoids provide control over cortical neurotransmission. We investigated the developmental expression of key genes in the endocannabinoid system across human postnatal life and determined whether they correspond to the development of markers for inhibitory interneurons, which shape cortical development. We used microarray with qPCR validation and in situ hybridisation to quantify mRNA for the central endocannabinoid receptor CB(1)R, endocannabinoid synthetic enzymes (DAGLα for 2-arachidonylglycerol [2-AG] and NAPE-PLD for anandamide), and inactivating enzymes (MGL and ABHD6 for 2-AG and FAAH for anandamide) in human dorsolateral prefrontal cortex (39 days - 49 years).

Results: CB(1)R mRNA decreases until adulthood, particularly in layer II, after peaking between neonates and toddlers. DAGLα mRNA expression is lowest in early life and adulthood, peaking between school age and young adulthood. MGL expression declines after peaking in infancy, while ABHD6 increases from neonatal age. NAPE-PLD and FAAH expression increase steadily after infancy, peaking in adulthood.

Conclusions: Stronger endocannabinoid regulation of presynaptic neurotransmission in both supragranular and infragranular cortical layers as indexed through higher CB(1)R mRNA may occur within the first few years of human life. After adolescence, higher mRNA levels of the anandamide synthetic and inactivating enzymes NAPE-PLD and FAAH suggest that a late developmental switch may occur where anandamide is more strongly regulated after adolescence than earlier in life. Thus, expression of key genes in the endocannabinoid system changes with maturation of cortical function.

Citing Articles

The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain.

Zhang M, Wang T, Meng F, Jiang M, Wu S, Xu H iScience. 2024; 27(12):111409.

PMID: 39717086 PMC: 11664153. DOI: 10.1016/j.isci.2024.111409.

Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence.

Rodrigues R, Marques J, Kofalvi A Cells. 2024; 13(22).

PMID: 39594623 PMC: 11593331. DOI: 10.3390/cells13221875.

Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer's Disease.

Dallabrida K, de Oliveira Bender J, Chade E, Rodrigues N, Sampaio T Brain Sci. 2024; 14(6).

PMID: 38928592 PMC: 11202267. DOI: 10.3390/brainsci14060592.

The Development of Cannabinoids as Therapeutic Agents in the United States.

Murray C, Gannon B, Winsauer P, Cooper Z, Delatte M Pharmacol Rev. 2024; 76(5):915-955.

PMID: 38849155 PMC: 11331953. DOI: 10.1124/pharmrev.123.001121.

Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans.

Wang Z, Arnold J Geroscience. 2024; 46(6):5643-5661.

PMID: 38696056 PMC: 11493940. DOI: 10.1007/s11357-024-01162-8.

References

Blankman J, Simon G, Cravatt B . A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol. 2007; 14(12):1347-56. PMC: 2692834. DOI: 10.1016/j.chembiol.2007.11.006. View

Volk D, Austin M, Pierri J, Sampson A, Lewis D . Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 2000; 57(3):237-45. DOI: 10.1001/archpsyc.57.3.237. View

Marrs W, Blankman J, Horne E, Thomazeau A, Lin Y, Coy J . The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci. 2010; 13(8):951-7. PMC: 2970523. DOI: 10.1038/nn.2601. View

Cohen M, Rasser P, Peck G, Carr V, Ward P, Thompson P . Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Int J Neuropsychopharmacol. 2011; 15(3):297-307. DOI: 10.1017/S146114571100068X. View

Mimmack M, Ryan M, Baba H, Iritani S, Faull R, McKenna P . Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A. 2002; 99(7):4680-5. PMC: 123707. DOI: 10.1073/pnas.032069099. View

Biegon A, Kerman I . Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. Neuroimage. 2001; 14(6):1463-8. DOI: 10.1006/nimg.2001.0939. View

Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M . The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 2006; 26(11):2991-3001. PMC: 6673964. DOI: 10.1523/JNEUROSCI.4872-05.2006. View

Berghuis P, Dobszay M, Wang X, Spano S, Ledda F, Sousa K . Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci U S A. 2005; 102(52):19115-20. PMC: 1323195. DOI: 10.1073/pnas.0509494102. View

Ueda N, Okamoto Y, Morishita J . N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines. Life Sci. 2005; 77(14):1750-8. DOI: 10.1016/j.lfs.2005.05.018. View

10.

Kang H, Kawasawa Y, Cheng F, Zhu Y, Xu X, Li M . Spatio-temporal transcriptome of the human brain. Nature. 2011; 478(7370):483-9. PMC: 3566780. DOI: 10.1038/nature10523. View

11.

Kozlovsky N, Shanon-Weickert C, Tomaskovic-Crook E, Kleinman J, Belmaker R, Agam G . Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J Neural Transm (Vienna). 2004; 111(12):1583-92. DOI: 10.1007/s00702-004-0166-3. View

12.

Hajos M, Hoffmann W, Kocsis B . Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry. 2008; 63(11):1075-83. DOI: 10.1016/j.biopsych.2007.12.005. View

13.

Luna B, Garver K, Urban T, Lazar N, Sweeney J . Maturation of cognitive processes from late childhood to adulthood. Child Dev. 2004; 75(5):1357-72. DOI: 10.1111/j.1467-8624.2004.00745.x. View

14.

Simon G, Cravatt B . Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J Biol Chem. 2008; 283(14):9341-9. PMC: 2431036. DOI: 10.1074/jbc.M707807200. View

15.

Ben-Ari Y, Gaiarsa J, Tyzio R, Khazipov R . GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev. 2007; 87(4):1215-84. DOI: 10.1152/physrev.00017.2006. View

16.

Whitfield Jr H, Brady L, Smith M, Mamalaki E, Fox R, Herkenham M . Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell Mol Neurobiol. 1990; 10(1):145-57. PMC: 11567182. DOI: 10.1007/BF00733641. View

17.

Eggan S, Mizoguchi Y, Stoyak S, Lewis D . Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb Cortex. 2009; 20(5):1164-74. PMC: 2852503. DOI: 10.1093/cercor/bhp179. View

18.

Chavez A, Chiu C, Castillo P . TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci. 2010; 13(12):1511-8. PMC: 3058928. DOI: 10.1038/nn.2684. View

19.

Webster M, Elashoff M, Weickert C . Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int J Dev Neurosci. 2010; 29(3):225-36. DOI: 10.1016/j.ijdevneu.2010.09.006. View

20.

Hashimoto T, Nguyen Q, Rotaru D, Keenan T, Arion D, Beneyto M . Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol Psychiatry. 2009; 65(12):1015-23. PMC: 2882199. DOI: 10.1016/j.biopsych.2009.01.004. View